These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22184924)

  • 1. An update on some structural aspects of the mighty miniwall.
    Markiewicz Z; Popowska M
    Pol J Microbiol; 2011; 60(3):181-6. PubMed ID: 22184924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural variation in the glycan strands of bacterial peptidoglycan.
    Vollmer W
    FEMS Microbiol Rev; 2008 Mar; 32(2):287-306. PubMed ID: 18070068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and metabolism of peptidoglycan and molecular requirements allowing its detection by the Drosophila innate immune system.
    Mengin-Lecreulx D; Lemaitre B
    J Endotoxin Res; 2005; 11(2):105-11. PubMed ID: 15949137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidoglycan biosynthesis machinery: a rich source of drug targets.
    Gautam A; Vyas R; Tewari R
    Crit Rev Biotechnol; 2011 Dec; 31(4):295-336. PubMed ID: 21091161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural perspective of peptidoglycan biosynthesis and assembly.
    Lovering AL; Safadi SS; Strynadka NC
    Annu Rev Biochem; 2012; 81():451-78. PubMed ID: 22663080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On structural aspects of peptidoglycan of bacterial cell wall with special attention on mycobacteria by computer modelling.
    Pain S; Bera A; Das M; Das BN; Banerjee A
    Indian J Lepr; 1992; 64(1):28-41. PubMed ID: 1573299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
    Stegmann E; Frasch HJ; Kilian R; Pozzi R
    Int J Med Microbiol; 2015 Feb; 305(2):190-5. PubMed ID: 25601631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific labeling of peptidoglycan precursors as a tool for bacterial cell wall studies.
    van Dam V; Olrichs N; Breukink E
    Chembiochem; 2009 Mar; 10(4):617-24. PubMed ID: 19173317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-Acetylated peptidoglycan: controlling the activity of bacterial autolysins and lytic enzymes of innate immune systems.
    Moynihan PJ; Clarke AJ
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1655-9. PubMed ID: 21889603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion to cell-penetrating peptides will enable lytic enzymes to kill intracellular bacteria.
    Borysowski J; Górski A
    Med Hypotheses; 2010 Jan; 74(1):164-6. PubMed ID: 19656633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity.
    Bera A; Biswas R; Herbert S; Götz F
    Infect Immun; 2006 Aug; 74(8):4598-604. PubMed ID: 16861647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of peptidoglycan in chlamydial cell division: towards resolving the chlamydial anomaly.
    Jacquier N; Viollier PH; Greub G
    FEMS Microbiol Rev; 2015 Mar; 39(2):262-75. PubMed ID: 25670734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new family of enzymes with potential O-acetylpeptidoglycan esterase activity in both Gram-positive and Gram-negative bacteria.
    Weadge JT; Pfeffer JM; Clarke AJ
    BMC Microbiol; 2005 Aug; 5():49. PubMed ID: 16111493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system.
    Boneca IG; Dussurget O; Cabanes D; Nahori MA; Sousa S; Lecuit M; Psylinakis E; Bouriotis V; Hugot JP; Giovannini M; Coyle A; Bertin J; Namane A; Rousselle JC; Cayet N; Prévost MC; Balloy V; Chignard M; Philpott DJ; Cossart P; Girardin SE
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):997-1002. PubMed ID: 17215377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis.
    Yuan Y; Barrett D; Zhang Y; Kahne D; Sliz P; Walker S
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5348-53. PubMed ID: 17360321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial SPOR domains are recruited to septal peptidoglycan by binding to glycan strands that lack stem peptides.
    Yahashiri A; Jorgenson MA; Weiss DS
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11347-52. PubMed ID: 26305949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of peptidoglycan-specific aptamers for bacterial cells identification.
    Ferreira IM; de Souza Lacerda CM; de Faria LS; Corrêa CR; de Andrade AS
    Appl Biochem Biotechnol; 2014 Dec; 174(7):2548-56. PubMed ID: 25185503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus.
    Bera A; Herbert S; Jakob A; Vollmer W; Götz F
    Mol Microbiol; 2005 Feb; 55(3):778-87. PubMed ID: 15661003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidoglycan structure and architecture.
    Vollmer W; Blanot D; de Pedro MA
    FEMS Microbiol Rev; 2008 Mar; 32(2):149-67. PubMed ID: 18194336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.